KHAYAL TAMER I (Chief Commercial Officer) received a stock award from TRANSMEDICS GROUP, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/26/2025ACC: 0000950170-25-028040
Officer· Chief Commercial Officer
Since May 2019
+44.10K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
44.10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+17.61K
Price / share
—
Trade value
—
% of position
84.5%
2/24/2025
20.84K→38.45K
Total
Net shares
+17.61K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2025 | A · Award | +17.61K | — | — | 84.5% | 20.84K | 38.45K |
| Total | +17.61K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
26.50K shares
Shares
+26.50K
Strike price
77.12
Held after
26.50K
Exercisable
—
2/24/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock26.50K shares | 2/24/2025 | A · Award | +26.50K | 77.12 | — | 26.50K |